Research
World class services
for your research
Clinical research in cardiovascular was and still remains one of the core objectives of the Institut Jantung Negara (IJN) since its inception in 1992. We are most dedicated to the treatment of cardiovascular disease and conscious for the need of research in this area. In line with national direction to promote clinical trial programs in this region, IJN has aspired to be the key player giving a full commitment and take lead to accelerate and foster the clinical research agenda, in particular cardiovascular diseases in this region.
Dato’ Dr. Suhaini Kadiman
Director of Clinical Research
INTRODUCTION
Clinical research in cardiovascular was and still remains one of the core objectives of the Institut Jantung Negara (IJN) since its inception in 1992. We are most dedicated to the treatment of cardiovascular disease and conscious for the need of research in this area. In line with national direction to promote clinical trial programs in this region, IJN has aspired to be the key player giving a full commitment and take a lead to accelerate and foster the clinical research agenda, in particular cardiovascular diseases in this region.
We have a number of collaboration research programs with local and international universities as a strategic approach to promote, encourage and bring cardiovascular research in IJN to a higher level. Through emphasizing observational studies and involvement in internationally recognized clinical trial activities, research agenda in IJN has continued to grow and produce interesting results. Our capacity to design, implement and coordinate a large number of clinical research has continued to improve and our contribution to the national community is now more recognized and aligned with national direction to establish clinical trial hubs in this region. Together with scientists and researchers from other academics and research institutes, IJN plays a leading role in these advances.
We are currently looking to recruit patients for the on-going studies.
OUR SERVICES
Clinical Trial Services
We work alongside healthcare professionals, investigators, and patients to ensure that trials are meticulously planned, conducted, and monitored.
Data Management & Biostatistical Support Services
We use state-of-the-art data management systems to extract meaningful insights from the vast amounts of data generated during trials.
CLINICAL RESEARCH PROGRAM
Clinical research plays a vital role in advancing our understanding of heart and vascular diseases, improving patient care, and developing innovative treatments and diagnostic tools.
Industry Sponsored Research
Investigator Initiated Research
Collaboration Research
RESEARCH ETHICS COMMITEE
Term of References (TOR)
The primary purpose of the IJNREC, a subcommittee of Research Committee, is to protect the rights and welfare of human subjects involved in research activities being conducted in Institut Jantung Negara (IJN).
Standard Procedure
A comprehensive guide outlines the meticulous procedures for the IJN Research Ethics Committee (IJNREC) application process, elucidating the steps for full board review and elucidating the protocols for safety reporting.
Membership and Meetings
Explore information about our members and stay updated on crucial meeting dates, where expertise comes together to maintain the utmost ethical standards and propel innovative initiatives in cardiovascular research forward.
Submission
Navigate through a streamlined process designed for ethical review of cardiovascular research. Access essential forms, ensuring a seamless submission experience.
FREQUENTLY ASKED QUESTIONS (FAQ)
Your go-to resource for understanding the ins and outs of clinical studies and trials. We know that navigating the world of clinical research can be complex, so we’ve compiled the answers to your most common questions to provide clarity and insight into various aspects of clinical trials.
If your question isn’t here, don’t hesitate to reach out to us directly. We’re here to help.
PUBLICATIONS
Clinical research plays a vital role in advancing our understanding of heart and vascular diseases, improving patient care, and developing innovative treatments and diagnostic tools.
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
Kandasamy, Balachandran for the ODYSSEY OUTCOMES Committees and Investigators
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
Kandasamy, Balachandran for the ODYSSEY OUTCOMES Committees and Investigators
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial